
Pharmaceutical Technology's In the Lab eNewsletter
A suitable tool for analyzing glycans in biopharmaceutical manufacturing is the growing use of analytical enzymes known as exoglycosidases.

Pharmaceutical Technology's In the Lab eNewsletter
A suitable tool for analyzing glycans in biopharmaceutical manufacturing is the growing use of analytical enzymes known as exoglycosidases.

Pharmaceutical Technology's In the Lab eNewsletter
In this article, industry experts explore efficient analytical practices and products for small-molecule lot release testing.

Pharmaceutical Technology's In the Lab eNewsletter
Cytek Biosciences’ Northern Lights series of advanced flow cytometry systems brings reagent and application flexibility to more labs while enhancing performance.

Pharmaceutical Technology's In the Lab eNewsletter
GiroNEX’s precision powder dispensing technology is expected to enable a new range of automated “dispense and weigh” systems for use in R&D and other lab-based applications.

Pharmaceutical Technology's In the Lab eNewsletter
Thermo Fisher Scientific’s Savant SpeedVac systems now offer preset and custom-made programs for improved application flexibility.

Pharmaceutical Technology's In the Lab eNewsletter
This new partnership provides access to Distributed Bio’s antibody discovery platforms.

Pharmaceutical Technology's In the Lab eNewsletter
The company has broken ground on the construction of a new laboratory space.

Pharmaceutical Technology's In the Lab eNewsletter
he acquisition expands the company’s formulation and analytical R&D services.

Pharmaceutical Technology's In the Lab eNewsletter
The company introduced a new approach to chemical imaging that provides enhanced clarity.

Pharmaceutical Technology's In the Lab eNewsletter
Research from Massachusetts Institute of Technology suggests that small chips could replace standard lab-scale spectrometry equipment for many applications.

Pharmaceutical Technology's In the Lab eNewsletter
The investment in the company’s Mississauga, Canada, laboratory includes an expansion of existing cell/tissue culture capabilities, flow cytometry, mass spectrometry facilities, and more.

Pharmaceutical Technology's In the Lab eNewsletter
Dr C. Frank Bennett, has been announced as a recipient of the Breakthrough Prize in Life Sciences in recognition of his contribution to the discovery and development of the first drug approved for the treatment of spinal muscular atrophy (SMA).

Pharmaceutical Technology's In the Lab eNewsletter
The company says the new equipment will reduce sample turnaround times and increase variant detection quality and accuracy.